- Release Date: 24/04/20 10:03
- Summary: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L
- Price Sensitive: Yes
- Download Document 144.87KB
-
- There are more pages in this discussion • 788 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.28 |
Change
-0.010(0.44%) |
Mkt cap ! $2.918B | |||
| Open | High | Low | Value | Volume |
| $2.26 | $2.31 | $2.25 | $3.299M | 1.443M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 36 | 65630 | $2.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.28 | 23049 | 5 |
View Market Depth
| Last trade - 15.05pm 12/08/2025 (20 minute delay) ? |
| MSB (ASX) Chart |